Dental Cleaning to Prevent Chronic Graft-Versus-Host Disease
This study is looking at whether dental cleanings can help prevent chronic graft-versus-host disease (GVHD) in people who have had a stem cell transplant (HCT). HCT is a treatment for some blood cancers, but it can sometimes lead to GVHD, where the new cells attack your body. Some research suggests that bacteria in your mouth might play a role in developing chronic GVHD. This trial will provide a dental cleaning around 28 days after your transplant. Researchers will then see if this helps reduce the chance of developing moderate-to-severe chronic GVHD one year after your transplant. You might be able to join if you are 18 or older, have had a specific type of HCT, and are willing to have a follow-up visit one year later. The current status of this study is unclear, and it plans to enroll 45 participants.
- Study design
- This is an interventional study planning to enroll 45 participants. It involves a dental cleaning procedure after a stem cell transplant.
- What's involved
- You would receive a simplified dental cleaning around 28 days after your transplant. You will then have follow-up visits on days +84, +180, and at 1 year.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants are followed up on days +84 and +180, and at 1 year after the intervention.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Dental Cleaning to Prevent Chronic Graft-Versus-Host Disease
At a glance
Conditions
NCT07535008
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washingtonstudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Armin Rashidi, MD, PhD · PRINCIPAL_INVESTIGATOR · Fred Hutch/University of Washington Cancer Consortium
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Probability of moderate-to-severe chronic graft versus host diseaseAt 1-year post-transplant